Rchr
J-GLOBAL ID：201901019478884085
Update date: Mar. 21, 2024
Chiharu Miyajima
Chiharu Miyajima
Affiliation and department：
Research field (1)：
Cell biology
Research theme for competitive and other funds (2)：
- 2021 - 2024 上皮間葉転換の生体内動態可視化によるがん転移の時空間的理解と新規治療法開発
- 2018 - 2022 The Role of Blood Fibrinolytic Factor Plasmin Activity in Manipulating Macrophage-mediated Mechanisms of Atherosclerosis Promotion
Papers (16)：
-
Mai Nagasaka, Chiharu Miyajima, Yasumichi Inoue, Sakura Hashiguchi, Yuya Suzuki, Daisuke Morishita, Hiromasa Aoki, Kohki Toriuchi, Ryohei Katayama, Mineyoshi Aoyama, et al. ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis. Biochemical and Biophysical Research Communications. 2024. 149789-149789
-
Mai Nagasaka, Yasumichi Inoue, Yuji Nagao, Chiharu Miyajima, Daisuke Morishita, Hiromasa Aoki, Mineyoshi Aoyama, Takeshi Imamura, Hidetoshi Hayashi. SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner. Scientific Reports. 2023. 13. 1
-
Muneshige Tokugawa, Yasumichi Inoue, Hiromasa Aoki, Chiharu Miyajima, Kan'ichiro Ishiuchi, Kento Tsurumi, Chisane Kujirai, Daisuke Morishita, Michiyo Matsuno, Hajime Mizukami, et al. Involvement of cardiac glycosides targeting Na/K-ATPase in their inhibitory effects on c-Myc expression via its transcription, translation, and proteasomal degradation. Journal of biochemistry. 2023
-
Mai Nagasaka, Chiharu Miyajima, Hiromasa Aoki, Mineyoshi Aoyama, Daisuke Morishita, Yasumichi Inoue, Hidetoshi Hayashi. Insights into Regulators of p53 Acetylation. Cells. 2022. 11. 23. 3825-3825
-
Chiharu Miyajima, Yurika Hayakawa, Yasumichi Inoue, Mai Nagasaka, Hidetoshi Hayashi. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals (Basel, Switzerland). 2022. 15. 8
ｍore...
Return to Previous Page
